Browse the evidence

A structured primary care intervention combining a phased caloric-restricted diet (initially low-carbohydrate) and progressive aerobic activity, delivered via frequent GP visits, produces statistically significant weight loss (≥5% and ≥10%) compared to usual care in patients with obesity.

If you have obesity, ask your doctor for a structured plan rather than general advice. Look for programs that include frequent check-ins, a written diet guide, and a specific exercise goal. The study showed that a strict 4-week start followed by a balanced diet and daily walking/cycling, managed by your doctor, leads to better weight loss than standard care.

Sedentary lifestyle and insufficient physical activity are significant behavioral factors contributing to obesity by reducing energy expenditure.

Increase daily movement by taking short walks, standing more, or doing light exercises during breaks. Aim for at least 30 minutes of physical activity per day to help control weight.

Low-calorie diets (1,000–1,500 kcal/day) are a foundational, guideline-recommended intervention for obesity management, though weight loss plateaus after 6 months.

Start with a daily intake of 1,000 to 1,500 calories, or a 500-750 calorie deficit, as recommended by major guidelines. Expect the most significant weight loss in the first 6 months, but plan for a maintenance phase afterward. Work with a nutritionist to ensure the diet fits your preferences to improve adherence.

Low energy availability (LEA) of 25 kcal/kg fat-free mass per day significantly reduces daily integrated myofibrillar and sarcoplasmic muscle protein synthesis in trained females, even when protein intake is maintained at 2.2 g/kg lean mass per day.

If you are a trained female athlete trying to build or maintain muscle while in a caloric deficit, simply eating high protein is not enough. You must ensure your energy availability is sufficient (above ~30 kcal/kg fat-free mass). Severe energy restriction will blunt muscle protein synthesis and lean mass gains, even with optimal protein intake. Focus on balancing energy intake with exercise expenditure.

Skeletal Muscle Mass (SMM) and Appendicular Lean Soft Tissue (ALST) are critical protective factors against frailty, diabetes, and mortality, and their loss (sarcopenia) is an independent risk factor for adverse health outcomes.

Prioritize resistance training to build and maintain muscle mass, especially as you age. Muscle is not just for aesthetics; it is your primary organ for glucose disposal and metabolic health. If you are losing weight, ensure you are doing resistance training and consuming adequate protein to prevent muscle loss, which can lead to frailty and weight regain.

Losing obesity (achieving non-obesity status) after having been obese in young adulthood normalizes the risk of MASLD, at-risk MASH, and increased liver stiffness to levels comparable to those who were never obese.

If you were obese in your young adulthood but have since lost the weight to a non-obese range, your risk for serious liver conditions (like MASH and fibrosis) is likely the same as someone who was never obese. You do not need to worry about 'permanent' liver damage from your past obesity if you have achieved and maintained a healthy weight.

Moderate and sustained weight loss through combined diet, exercise, and lifestyle modifications improves blood glucose levels, insulin action, and reduces the need for diabetic medications in individuals with obesity and type 2 diabetes.

If you have obesity and Type 2 Diabetes, losing weight is the most critical step you can take to improve your health. You don't need a specific pill or extreme diet; focus on a sustainable combination of eating less, moving more, and changing daily habits. This approach directly improves how your body handles sugar and insulin, potentially reducing your need for medication.

Sustained weight loss of at least 15% significantly improves glycemic control, reduces cardiometabolic risk, and can induce remission of Type 2 Diabetes (T2DM).

To potentially reverse Type 2 Diabetes, aim for a sustained loss of 15% or more of your body weight. This threshold is linked to significant improvements in blood sugar control and reduced heart disease risk. Be aware that maintaining this loss is biologically challenging due to appetite changes, so long-term strategies (like medication or surgery) may be necessary to support this goal.

Low muscle glycogen availability prior to soccer match-play causes early fatigue, characterized by reduced high-intensity sprinting and increased low-intensity walking, whereas maintaining normal glycogen stores preserves high-intensity performance.

Ensure you have high muscle glycogen stores before kickoff. If you start with low glycogen, you will likely slow down, walk more, and sprint less effectively. Prioritize carbohydrate intake in the days leading up to the match to maintain 'normal' glycogen levels and preserve high-intensity performance.

Among patients receiving intensive lifestyle intervention, achieving ≥10% weight loss in the first year is associated with a significant reduction in all-cause mortality compared to the control group.

If you are doing an intensive lifestyle program for type 2 diabetes, aim for 10% weight loss in the first year, as this specific threshold is associated with lower mortality risk. However, even if you don't reach 10%, the health benefits for blood pressure, fitness, and quality of life are still valuable.

Calorie restriction (CR) of 25-30% without malnutrition improves cardiometabolic risk factors (body composition, lipids, glucose, inflammation) and may extend healthy lifespan.

Reduce your daily calorie intake by 25-30% while ensuring you still get all essential nutrients. This can be done continuously or via intermittent fasting patterns. Combining this with exercise yields the best cardiovascular outcomes.

Weight loss, particularly >10% body weight reduction, significantly reduces atrial fibrillation burden and increases the probability of arrhythmia-free survival.

If you have atrial fibrillation and are obese, losing more than 10% of your body weight and keeping it off dramatically increases your chances of being free from AF. This benefit is seen even if you don't undergo ablation or take more anti-arrhythmic drugs.

Significant weight loss (typically >15 kg or >15% of baseline weight) induced by dietary interventions (Very Low-Calorie Diets or Low-Carbohydrate Diets) is the strongest predictor of Type 2 Diabetes remission, regardless of the specific macronutrient composition.

To achieve diabetes remission through diet, the primary goal is significant weight loss (over 15kg). Whether you choose a very low-calorie diet or a low-carb diet, the magnitude of weight loss matters more than the specific type of diet. Medical supervision is recommended for very low-calorie diets.

Weight loss of ≥10% sustained over the long term reduces atrial fibrillation burden and improves arrhythmia-free survival in obese patients.

If you have atrial fibrillation and obesity, losing at least 10% of your body weight and keeping it off can significantly reduce your AF symptoms and recurrence. This requires a comprehensive approach to managing your overall health, not just weight loss alone.

Bariatric surgery reduces major cardiovascular events, particularly coronary artery disease, and mortality in overweight and obese heart failure patients compared to non-surgical weight management.

For obese patients with heart failure or coronary artery disease, bariatric surgery can significantly reduce major cardiovascular events and mortality compared to non-surgical weight management. It should be considered as part of a comprehensive management plan.

Higher adherence to the DASH diet is inversely associated with adiposity measures, including BMI, body fat percentage, and visceral adipose tissue (VAT), in young adults.

Improving your DASH score not only helps your blood sugar but also helps manage body fat and visceral fat. By focusing on the components of the DASH diet (more fruits, vegetables, whole grains, low-fat dairy, less sodium and saturated fat), you can naturally support a healthier body composition without necessarily needing to restrict calories aggressively.

Dietary fiber intake influences gut microbiota composition and short-chain fatty acid generation, which decreases inflammation and supports gut barrier maintenance, thereby potentially lowering type 2 diabetes risk.

Eat a high-fiber diet rich in minimally processed plant foods like whole grains, vegetables, fruits, legumes, nuts, and seeds. This promotes gut bacterial diversity and produces beneficial fats (SCFAs) that reduce inflammation and support your gut barrier. Because your unique gut bacteria determine how you respond, start slowly if you are not used to high fiber.

Modest weight loss of 3-5% yields clinically meaningful health benefits, but progressive weight loss beyond 15% is required for disease modification in T2D.

You do not need to lose 15% of your body weight to see health benefits. Losing just 3-5% of your weight produces clinically meaningful improvements. However, if your goal is to potentially reverse type 2 diabetes entirely, you need to aim for a larger loss of over 15%. Start with the smaller goal to get immediate health wins, then build toward the larger target.

Lifestyle interventions remain critical for optimizing body composition (preserving lean mass) and improving cardiovascular fitness, outcomes that AOMs alone do not fully address.

When using AOMs, prioritize protein intake and resistance/cardio exercise. This ensures you lose fat rather than muscle and improves your heart health, maximizing the 'quality' of the weight loss.

Achieving a total body weight loss of 5% or higher in individuals with type 2 diabetes and obesity significantly improves glycemic control (reducing HbA1c) and reduces the utilization of glucose-lowering medications.

If you have type 2 diabetes and are overweight or obese, aiming to lose at least 5% of your body weight is a critical first step. This modest loss can significantly improve your blood sugar levels and may allow you to reduce your diabetes medications. Focus on sustainable lifestyle changes involving diet, exercise, and behavioral support rather than just medication adjustments.

Achieving a total body weight loss of 10% or more in individuals with type 2 diabetes leads to progressive improvements in glycemic control and cardiometabolic risk factors, and may be necessary to reduce mortality.

If you have type 2 diabetes, aiming for 10% or more weight loss can provide even greater benefits for your heart health and longevity than the standard 5% goal. This may require more intensive lifestyle changes or medical support, but the potential to reduce cardiovascular events and death makes it a worthwhile target for many patients.

Weight loss of at least 10% of total body weight reverses steatohepatitis and improves histologic fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).

To reverse liver inflammation and scarring, you need to lose at least 10% of your body weight. While losing just 3-5% helps reduce liver fat, it is not enough to fix the underlying disease. Focus on sustainable dietary changes and regular exercise to reach this higher threshold.

Maintaining a body weight loss of ≥7% of baseline (high Time in Target Range, TTR) is independently associated with a significantly lower risk of major adverse cardiovascular events in adults with overweight/obesity and type 2 diabetes, independent of mean body weight and weight variability.

For adults with type 2 diabetes and obesity, the key to reducing cardiovascular risk is not just losing weight, but keeping it off. Aim to maintain a 7% weight loss from your starting weight. Track your 'Time in Target Range' (TTR)—the percentage of time you stay within this 7% loss zone. Higher TTR is strongly linked to lower heart disease risk, independent of your average weight or how much it fluctuates. Focus on consistency and maintenance over the long term (years, not weeks).

Modest weight loss of 5–10% significantly improves cardiovascular and metabolic risk factors, whereas weight loss of ≥10% is required to reduce major cardiovascular events.

Focus on achieving a 5-10% weight reduction as a primary clinical goal for improving metabolic health markers like blood pressure and lipids. If the patient has established cardiovascular disease, aim for at least 10% weight loss to significantly lower the risk of major cardiovascular events. This can be achieved through lifestyle modifications, and if insufficient, anti-obesity medications or bariatric surgery should be considered.